Now that would increase the stock price, CEO Paul Perreault said it would be a block buster billion dollar generator.
Old figures from 2016, but do your own Google research if you want to know more:
"A billion reasons to love CSL's new drug
A cholesterol killer decades in the making could be a game changer for CSL.
How to value hope though it's a long shot, we can't ignore CSL-112's potential. Citigroup research estimates that the therapy could add around US$1.0bn to net profit within five years of launch. That seems reasonable – if not conservative – given that the current market for cholesterol-lowering drugs is around US$30bn a year and the margins on CSL-112 would be mouth watering because CSL would manufacture it using the waste portion of its existing plasma supply. Taking CSL's current forward price-earnings ratio of 27, an extra billion in net profit might mean another US$27bn added to the company's market cap – or $77 per share."
LINK
- Forums
- Charts
- CSL possible pull back to low $200's
Now that would increase the stock price, CEO Paul Perreault said...
-
-
- There are more pages in this discussion • 236 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$303.99 |
Change
0.890(0.29%) |
Mkt cap ! $147.1B |
Open | High | Low | Value | Volume |
$302.12 | $305.00 | $300.79 | $155.5M | 515.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 330 | $303.79 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$304.25 | 386 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100 | 302.840 |
1 | 2 | 301.750 |
1 | 100 | 301.380 |
1 | 2 | 301.000 |
1 | 55 | 300.980 |
Price($) | Vol. | No. |
---|---|---|
304.650 | 70 | 1 |
304.810 | 21 | 1 |
305.000 | 2004 | 17 |
305.010 | 285 | 1 |
305.100 | 35 | 1 |
Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |